专利知识系列问答(一)

2015-08-19 MedSci MedSci原创

(一)问:拥有专利有什么作用?答:例举主要的四项1)可帮助“积分落户”,例如:A.上海市,非上海生源应届高校毕业生落户评分标准中规定,拥有发明专利证书加5分,实用新型专利证书加3分,外观设计专利证书加3分,拥有发明专利受理通知书加1分。B.深圳市,积分落户政策中规定,拥有发明专利加50分,实用新型专利加10分。C.中山市,拥有发明专利加30分,实用新型加20分,外观设计加10分。2)专利可用于

(一)
问:拥有专利有什么作用?
答:例举主要的四项

1)可帮助“积分落户”,例如:
A.上海市,非上海生源应届高校毕业生落户评分标准中规定,拥有发明专利证书加5分,实用新型专利证书加3分,外观设计专利证书加3分,拥有发明专利受理通知书加1分。
B.深圳市,积分落户政策中规定,拥有发明专利加50分,实用新型专利加10分。
C.中山市,拥有发明专利加30分,实用新型加20分,外观设计加10分。

2)专利可用于评定“职称”,例如:
A.《北京市专利保护和促进条例》中提到,职称评审时,将相关专利作为评价考核的重要因素,对产生重大作用、取得显著经济或社会效益的专利,作为破格申报职称考核的重要因素。
B.《关于推进上海市卫生系统知识产权工作的若干意见》中提到,将专利纳入科技创新管理评定指标体系,将知识产权拥有量作为评定各项工作的重要指标和条件。
C.《江苏省专利促进条例》中提到:专业技术职称评审时,专利作为评审的依据之一,对产生重大作用或取得显著经济效益的专利,作为破格申报职称的依据,对获得专利金奖、优秀奖及省优秀专利项目奖等可以破格申报相关技术职称。

3)专利可获得科研经费资助,例如:
A.《广州市专利奖励办法》中提到,市政府设立专利奖,金奖奖励20万元/项,优秀奖奖励10万元/项;获得国家专利金奖,奖励20万元/项,获国家专利优秀奖,奖励10万元/项。
B.《广东省专利奖励办法》中提到,获得广东专利金奖奖励10万元/项,广东专利优秀奖奖励5万元/项;获得中国专利金奖,奖励100万元/项,获中国外观设计金奖,奖励100万元/项,获中国专利优秀奖,奖励50万元/项,获中国外观设计优秀奖,奖励50万元/项。
C.《北京市发明专利奖励办法》中提到,北京市发明专利奖一等奖,奖励20万元/项;二等奖,奖励10万元/项;三等奖,奖励5万元/项;特等奖,奖励100万元/项。

4)技术拥有法律的保护效力,例如:
A.专利遵循先申请原则,避免自己的技术反被他人使用。
B.技术申请专利后,可以发表论文或进行学术会议,均是在法律保护下的技术公开。
C.可将专利权转让,获得收益;或将专利权转化成产品,取得市场效益。

(二)
问:专利和论文都可以评职称,有什么区别?
答:科技成果的主要体现形式为专利和论文,两者同样重要,而且对科研工作者可以并存,并不矛盾;为满足专利技术具有新颖性,应首先申请专利,再发表论文。
A.专利:可用于评职称;可将专利权转让或许可他人使用,获得收益;技术受法律保护。
B.论文:可用于评职称;获得学术上的认同,获得荣誉以及著作权。

(三)
问:如何申请专利?
答:可以将自己的技术(例如原始实验记录、产品结构图、论文等方式),最好是技术内容较为完整,与梅斯医学联系,梅斯医学会告知技术是否可以申请专利,以及申请专利的后续流程。

(四)
问:专利申请过程是否复杂?
答:不复杂,但属于专业性较强的程序。
第一阶段:梅斯医学对技术进行评估、指导。
第二阶段:代理机构撰写文件,提交申请。
第三阶段:国家知识产权局对专利审查,批准授权。

(五)
问:专利申请的专业性体现在哪?
答:评估技术是否可以申请专利,专利申请的流程,缴费或其他程序办理的时限把握,专利申请文件的撰写,专利审查意见的答复形式等。

(六)
问:专利技术有哪些要求?
答:专利技术要求具备新颖性、创造性、实用性;专利技术要求是健康的,不是违法的;是一种具有创新的产品或实验方法,并可以重现实施。
A.新颖性:是指技术不属于现有技术,即未被公开的技术。
B.创造性:是指与现有技术相比,具有一定的进步性。
C.实用性:是指技术可重现和实施。

(七)
问:哪些技术明确规定不能申请专利?
答:因专利是具有法律效力的文件,因此,基于道德尺度存在少数不能申请专利情形。例如:
A.技术不能是原理或功能介绍,因其不具有可实施的实用性。
B.违法的行为,科学发现,天然物质,智力活动的规则和方法,不能申请专利。
C.疾病的诊断和治疗方法,用原子核变换方法获得的物质,不能申请专利。

(八)
问:专利还有哪些特点?
答:1)我国专利分为三种类型:发明专利,实用新型专利,外观设计专利。
A.发明:是三种类型中技术含量最高的,可保护产品或方法,并具有一定创新的技术。
B.实用新型:是对具有结构产品的一种保护。
C.外观设计:是对产品外观的一种保护。

2)专利具有独占性、地域性、时间性的特点
A.独占性:专利权归属申请人所有,在市场具有垄断作用。
B.地域性:世界范围内,法律健全的国家都有自己的专利制度,在不同国家取得的专利权仅在当国有效。
C.时间性:专利法给予专利保护的期限,发明专利权保护期限为20年,实用新型和外观设计均为10年。

(九)
问:为什么给专利设定上述特征?
答:1)因为专利是具有法律效力的,因此,会设定少数不适合申请专利的情况,以免某些技术取得法律效力后,阻碍科技进步,危害社会秩序。
2)专利的保护期限,实际是给予了专利权人一定期限的市场垄断,为其发明创造所付出的劳动取得相应的回报。
3)专利技术要求具体实用性,即是对自己也是对他人的需求设定,比如在专利权保护期限后,其他人也可以实施该项技术,只有这样,才能实现创新技术促进社会的科技进步。

(十)
问:专利的全球效应是什么?
答:1)几乎所有法律健全的国家,都有自己的专利法。
2)纵观全球,越是经济发达的国家,专利制度实施的越早;现今专利保护做的比较好的地区为美国、日本、欧洲。
3)国外的专利法实施有300年历史,我国专利法实施有30年历史(1985年正式制定《专利法》)。
4)我国1980年加入世界知识产权组织(WIPO);1985年成为《巴黎公约》成员国;1994年成为《专利合作条约》成员国;我国2001年成为世界贸易组织(WTO)成员,使我国的知识产权制度与世贸组织的《与贸易有关的知识产权协议》相适应。
5)我国从维护自己的创新技术、鼓励科技创新、开展国际贸易、引进科技技术等角度出发,都应重视专利,专利制度在维护国家以及个人的科技创新方面的作用不可或缺。

了解更多相关专利知识,推荐大家观看由MedSci推出的关于专利的系列课程下载MedSci医学APP,也可在手机上观看。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    好东西,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    好东西,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    涨知识,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2016-01-12 medsic

    涨知识,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2015-09-08 Dr.LV

    学习啦

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2015-08-20 ndd99

    这个是空白

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2015-08-20 lyrichen

    专利…

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=56176, encodeId=e0bd561e689, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56177, encodeId=8965561e7aa, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:56:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56172, encodeId=e797561e2c5, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56173, encodeId=03a8561e394, content=好东西,, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56174, encodeId=4695561e42b, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56175, encodeId=50f7561e533, content=涨知识,, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 09:55:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36498, encodeId=05a63649857, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Tue Sep 08 22:45:00 CST 2015, time=2015-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35893, encodeId=13b635893b7, content=这个是空白, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=126b110623, createdName=ndd99, createdTime=Thu Aug 20 20:48:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35881, encodeId=36a0358813a, content=专利…, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7311615220, createdName=lyrichen, createdTime=Thu Aug 20 12:42:00 CST 2015, time=2015-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35848, encodeId=5066358487d, content=专利的确是不错的东西。, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XwAoQuU7Z2gufPeSOaUjyjfxUfz6oDxqo34cdWqzeiaib21keoMpic4tWFcrTGbxe2wVythia62RftA6nZJOgb39uw/132, createdBy=213c1639693, createdName=1dda0a02m51(暂无匿称), createdTime=Wed Aug 19 16:28:00 CST 2015, time=2015-08-19, status=1, ipAttribution=)]
    2015-08-19 1dda0a02m51(暂无匿称)

    专利的确是不错的东西。

    0